| 1 |
 |
Front Cover |
| 2 |
|
Inside Front Cover
|
| 3 |
|
Table of contents |
| 4 |
|
Letter from Rick Doblin, Ph.D. |
| 7 |
|
MDMA-Assisted Psychotherapy
in the Treatment of Posttraumatic
Stress Disorder (PTSD): A Third Update on the
Approval Process
Michael Mithoefer, M.D. |
| 9 |
|
Obtaining an Independent Supply of Research Marijuana:
The First of Two Prerequisites to a Realistic
Medical Marijuana Research Effort
Rick Doblin, Ph.D. |
| 14 |
|
The Struggle to Resume Ketamine Psychotherapy Studies
in St. Petersburg
Evgeny Krupitsy, M.D., Ph.D. |
| 15 |
|
Update From Lisa
A Sexual Assault Survivor Who Benefited From MDMA |
| 16 |
|
Ibogaine: Treatment Outcomes and Observations
Two ibogaine treatment providers |
| 22 |
|
New MDMA Research
at the 65th Annual Meeting of the
College on Problems of Drug Dependence (CPDD) - June
14-19, 2003, Sheraton Bal Harbour, Miami, Florida
Matthew Baggott |
| 25 |
|
The GHB National Conference
A Visit to a Different Kind of Drug Activist Community
Valerie Mojeiko |
| 27 |
|
The Third National Clinical Conference on Cannabis Therapeutics |
| 28 |
|
Lending a Hand at Burning Man:
Psychedelic Emergency Services in the Black Rock Desert
Brandy Doyle |
| 32 |
|
Beyond Belief - Exactly!
"Sam", an underground psychedelic therapist |
| 33 |
|
Not Your Father's Revolution:
Two Summer Conferences and the Next Generation of Psychedelics, Spirituality,
and Community-building
Valerie Mojeiko and Brandy Doyle |
| 37 |
|
A Review
of Practicing Harm Reduction Psychotherapy
by Patt Denning
Bruce Sewick, MA, LCPC |
| 39 |
|
Letters to the Editors |
| 42 |
|
Membership & Donation Pages |
| 43 |
|
Inside Back Cover |
| 43 |
|
Back Cover |
| |
|
|
| MAPS (Multidisciplinary Association for Psychedelic Studies) is
a membership-based organization working to assist psychedelic
researchers around the world design, obtain governmental
approval, fund, conduct and report on psychedelic research
in humans. Founded in 1986, MAPS is an IRS approved 501
(c)(3) non-profit corporation funded by tax-deductible donations.
MAPS is now focused primarily on assisting scientists to
conduct human studies to generate essential information
about the risks and psychotherapeutic benefits of MDMA, other
psychedelics, and marijuana, with the goal of eventually
gaining government approval for their medical uses. Interested
parties wishing to copy any portion of this publication are
encouraged to do so and are kindly requested to credit MAPS
including name and address. The MAPS Bulletin is produced by
a small group of dedicated staff and volunteers. Your participation,
financial or otherwise, is welcome. |
© 2003 Multidisciplinary Association
for Psychedelic Studies, Inc. (MAPS)
Edited by Rick Doblin, Brandy Doyle
& Valerie Mojeiko
ISSN 1080-8981
Printed on recycled paper |
| |
|
|
